Post

New research · Ophthalmology
Ophthalmic plastic and reconstructive surgery · 12h
Cohort studyOphthalmic plastic and reconstructive surgery · 2026

Efficacy of Topical Chemotherapy in Ocular Adnexal Sebaceous Carcinoma.

Andrew J Rong, Matthew Camacho, Sander R Dubovy … Nathan W Blessing
Read paper
OphthalmologyCohort study

Topical chemotherapy failed to control intraepithelial spread in most sebaceous carcinoma cases.

Efficacy of Topical Chemotherapy in Ocular Adnexal Sebaceous Carcinoma.

Andrew J Rong … Nathan W Blessing
Ophthalmic plastic and reconstructive surgery · 2026
Purpose

This study aimed to report clinical outcomes of topical chemotherapy for ocular adnexal sebaceous carcinoma (OaSC) with intraepithelial spread.

Methods

We reviewed 120 patients with OaSC and 10 patients met the inclusion criteria (n = 10).

n = 120 patients
Results

chemo failed to clear early spreading skin cancer cells in most patients

80%
Inadequate control
20%
Resolution of pagetoid
More results

Patient inclusion criteria included: (1) biopsy-proven diagnosis of OaSC, (2) intraepithelial pagetoid involvement confirmed by conjunctival map biopsy, (3) implementation of topical chemotherapy for tumor control, and (4) repeat conjunctival map biopsy following cessation of topical chemotherapy.

More results

Topical chemotherapy agents were utilized via monotherapy or in combination and included mitomycin C (mitomycin C) 0.02% or 0.04% (8 cases), 5-fluorouracil 1% (3 cases), and interferon alpha-2a 1 million units/ml (2 cases).

Resolution of pagetoid disease was achieved in 2 patients (2/10, 20%) with mitomycin C monotherapy.

“
Conclusion

Topical mitomycin C may be used in the neoadjuvant setting for OaSC with pagetoid spread; however, additional studies are needed to determine the optimal dosing and treatment duration to minimize adverse effects and reduce ocular surface comorbidity.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment